Medicine and Dentistry
Heart Right Ventricle Failure
100%
Pulmonary Hypertension
80%
Empagliflozin
70%
Monocrotaline Pyrrole
70%
Semaxanib
70%
Pneumonectomy
70%
Right Ventricular Hypertrophy
70%
Right Ventricular Function
44%
Systolic Blood Pressure
37%
Echocardiography
33%
Heart Output
31%
Hypoxia
31%
Intubation
23%
Pulmonary Vasculature
19%
Hemodynamic
15%
Vascular Remodeling
15%
Ventricular Dysfunction
14%
Cardiovascular Disease
11%
Silo-Filler's Disease
11%
Cardiac Catheterization
11%
Ligation
11%
Reproductive Medicine
11%
Heart Right Ventricle Pressure
11%
Phenotype
11%
Diastolic Function
9%
Erythromycin Ethylsuccinate
9%
Diuresis
9%
Cardiac Magnetic Resonance Imaging
9%
Systolic Function
9%
Blood Glucose
9%
Sodium Glucose Cotransporter 2 Inhibitor
9%
Hematocrit
9%
Water Intake
9%
Left Ventricle
9%
Heart Right Ventricle Function
9%
Lung Surgery
9%
Monocrotaline
7%
Persistent Fetal Circulation
7%
Neointima
7%
Hypoxic Response
7%
Vasculotropin
7%
Pharmacology, Toxicology and Pharmaceutical Science
Heart Right Ventricle Failure
100%
Pulmonary Hypertension
97%
Semaxanib
70%
Monocrotaline Pyrrole
70%
Empagliflozin
70%
Mouse
70%
Dopamine Beta Monooxygenase
70%
Noradrenalin
35%
Heart Ventricle Remodeling
35%
Hypoxia
31%
Wistar Rat
27%
Ivabradine
17%
Vascular Remodeling
15%
Diuretic Agent
9%
Preclinical Study
9%
Clinical Study
9%
Erythromycin Ethylsuccinate
9%
Sodium Glucose Cotransporter 2 Inhibitor
9%
Persistent Pulmonary Hypertension
7%
Monocrotaline
7%
Neointima
7%
Vasculotropin
7%
C57BL 6 Mouse
7%
Inflammation
7%
Mouse Model
7%
Keyphrases
Pressure Overload
70%
Monocrotaline Pyrrole
70%
Pneumonectomy
70%
Right Ventricular Remodeling
31%
Angioproliferation
11%
Pulmonary Overcirculation
11%
Two-hit
11%
B6 Mice
11%
Echocardiographic Images
7%
Right Ventricular Myocardium
7%
